mRNA shots for dairy bird flu in development
Producers are developing an mRNA vaccine aimed at protecting dairy cows from bird flu to safeguard herd health and milk production. The initiative frames vaccination as a production-protection step rather than a consumer milk-testing measure (in.edairynews.com).
Messenger RNA vaccines — shots that teach the immune system to recognize a virus by showing it one of its proteins — are now being tested for bird flu in dairy cows. Early studies found they cut illness and viral shedding, and the United States Department of Agriculture says several cattle vaccine candidates are in field trials. (biorxiv.org) (aphis.usda.gov) Bird flu was first confirmed in a United States dairy herd on March 25, 2024, and the virus has since spread through dairy cattle in multiple states. The Centers for Disease Control and Prevention said on March 6, 2026, that outbreaks in dairy cows are continuing and that 41 of 71 reported United States human cases since 2024 were linked to dairy-herd exposure. (cdc.gov 1) (cdc.gov 2) In cows, the virus does not mainly act like a lung infection. Researchers at the University of Pennsylvania and the United States Department of Agriculture wrote that H5N1 replicates primarily in the mammary gland, causing sharp drops in milk production and spreading through virus shed in milk. (biorxiv.org) That is why the vaccine push is aimed at herd health and farm output as much as infection control. The United States Department of Agriculture said affected producers can receive compensation for lost milk production, and the American Veterinary Medical Association lists reduced appetite, lower milk yield, and thickened or discolored milk among the common signs in infected cows. (aphis.usda.gov) (avma.org) The milk-safety question runs on a separate track. The Food and Drug Administration said it had tested 464 pasteurized dairy products and found all were negative for viable H5N1, and the agency says multiple studies show pasteurization inactivates the virus. (fda.gov) The newest cattle data are still early. A March 2026 preprint from University of Pennsylvania and United States Department of Agriculture researchers said an H5 messenger RNA vaccine in lactating dairy cows produced strong antibodies in blood and milk and significantly reduced viral replication and disease after an udder challenge. (biorxiv.org) A separate peer-reviewed paper published in January 2026 reported that an H5 messenger RNA vaccine was well tolerated in high-yielding lactating cows, did not reduce milk production, and fully protected vaccinated cattle against a high-dose H5N1 challenge two weeks after the second shot. Two-thirds of the animals remained completely protected 19 weeks after the first vaccination. (pmc.ncbi.nlm.nih.gov) Commercial products are moving in parallel with the academic work. Zoetis said it has received a conditional license from the United States Department of Agriculture for an H5N2 killed-virus avian influenza vaccine for use in lactating dairy cattle, while also noting that vaccination decisions rest with regulators and industry authorities. (zoetis.com) Federal regulators have not yet announced a broad cattle-vaccination campaign. The United States Department of Agriculture said several dairy-cow vaccine candidates remain in field trials, and the next step is approval based on the agency’s science-based review. (aphis.usda.gov) For now, the outbreak response still leans on testing, movement controls, and farm biosecurity. The vaccine work is focused on a narrower problem: keeping infected cows from getting sick, losing milk, and shedding as much virus into the dairy barn. (aphis.usda.gov) (biorxiv.org)
